Search

everythinglearnresearchcommunity

for

Search:↓

Hormones control reproduction and are crucial for body balance.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Treatments for hair loss vary, but cell-based options may be the future.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Androgenetic alopecia in women needs more research and better management strategies.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.